PharmaTimes Magazine

PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.

Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.

You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.

Magazine highlights

View more from the latest edition
Thumbnail image for Trusting pharma

Trusting pharma

ViiV Healthcare has once again topped the annual PatientView corporate reputation survey. Dr Oleksandr Gorbenko, the company’s director, global patient affairs, explains the company’s views on how pharma should build trust with patients

Thumbnail image for SmartPeople: Bill Byrom

SmartPeople: Bill Byrom

With over 25 years experience in clinical development and as an eClinical thought leader and strategist, Bill Byrom is an expert on innovating clinical research. Now he has joined CRF Health as vice president of product strategy & innovation to define their product development vision

Thumbnail image for Pharma and data: Knowledge is power

Pharma and data: Knowledge is power

Sanofi’s Milind Kamkolkar is the first enterprise chief data officer in a major pharmaceutical company, and he has been outspoken about the need for pharma to adapt to the new digital world of AI, real-world evidence and prolific data. We caught up with him on the show floor at eyeforpharma Barcelona 2018

Thumbnail image for Company focus: Exscientia

Company focus: Exscientia

With several high-profile collaborations under its belt, Exscientia is bringing AI tech straight to the heart of pharma R&D. We asked the company's founder, Professor Andrew Hopkins, to explain how they’re hoping to make long, expensive drug development a thing of the past

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download